But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 ...
Health insurance companies gained today with shares of Humana Inc. ( NYSE:HUM ), UnitedHealth Group ( NYSE:UNH) and CVS ...
Hosted on MSN2d
UnitedHealth marked up lifesaving drugs by up to 1,000%: FTCAccording to the Federal Trade Commission, UnitedHealth Group has been charging patients markups on lifesaving drugs. Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS ...
(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs ...
(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback